Seer, Inc.
NASDAQ:SEERBiotechnology
+$0.01 today
- Market cap
- $77.30M
- Beta
- 1.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.26
Volume 0.25M
Average 0.32M
Balance Sheet
Inspect the capital base behind the business.
Assets
$296.08M
FY 2025 · Annual
-19.2% YoYLiabilities
$36.78M
FY 2025 · Annual
-5.8% YoYEquity
$259.31M
FY 2025 · Annual
-20.8% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 232.81M | 53.21M | 32.5M | 40.75M | 47.29M |
| Short-term Investments | 167.26M | 368.03M | 283.73M | 195.66M | 138.61M |
| Net Receivables | 4.14M | 7.02M | 6.72M | 6.23M | 5.95M |
| Inventory | 4.15M | 4.63M | 4.49M | 7.44M | 7.8M |
| Other Current Assets | 0 | 2.1M | 3.08M | 3.25M | 1.89M |
| Total Current Assets | 411.7M | 434.98M | 330.51M | 253.32M | 201.53M |
| Property, Plant & Equipment (Net) | 33.23M | 46.41M | 47.37M | 41.37M | 35.24M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 93.19M | 5.16M | 56.86M | 63.1M | 54.69M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.03M | 1.38M | 1.53M | 8.81M | 4.62M |
| Total Non-current Assets | 127.44M | 52.95M | 105.76M | 113.27M | 94.55M |
| Total Assets | 539.14M | 487.93M | 436.27M | 366.6M | 296.08M |
| Account Payables | 3.79M | 2.1M | 1.37M | 4.62M | 5.61M |
| Short-term Debt | 0 | 0 | 2.3M | 2.31M | 0 |
| Tax Payables | 457K | 335K | 501K | 471K | 0 |
| Deferred Revenue | 376K | 133K | 206K | 408K | 341K |
| Other Current Liabilities | 4.73M | 6.35M | 2.73M | 1.54M | 5.63M |
| Total Current Liabilities | 13.42M | 12.58M | 13.22M | 15.33M | 15.69M |
| Long-term Debt | 0 | 0 | 0 | 0 | 21.08M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 341K | 320K | 179K | 48K | 8K |
| Total Non-current Liabilities | 22.8M | 28.35M | 26.14M | 23.7M | 21.09M |
| Total Liabilities | 36.22M | 40.94M | 39.37M | 39.03M | 36.78M |
| Common Stock | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | (126.53M) | (219.5M) | (305.77M) | (392.37M) | (465.97M) |
| Accumulated OCI | (536K) | (1.25M) | (192K) | 136K | 459K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 502.92M | 446.99M | 396.9M | 327.57M | 259.31M |
| Total Debt | 23.32M | 29.87M | 28.26M | 25.96M | 23.65M |
| Net Debt | (209.49M) | (23.33M) | (4.24M) | (14.79M) | (23.63M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $47.3M |
| Short-term Investments | $119.4M |
| Receivables | $4.3M |
| Inventory | $8.1M |
| Other Current | $2.6M |
| Total Current Assets | $181.6M |
| PP&E (Net) | $33.4M |
| Long-term Investments | $52.8M |
| Other Non-current | $4.3M |
| Total Non-current Assets | $90.5M |
| Total Assets | $272.1M |
Analysis
Selected assets total $272.1M for Latest. The largest visible component is Short-term Investments at $119.4M, about 43.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
Market cap
$10.89B
Pharvaris N.V.
NASDAQ:PHVS
Market cap
$2.34B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
Market cap
$1.69B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
Market cap
$1.36B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
Market cap
$814.71M
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
Market cap
$800.67M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
Market cap
$667.39M
Sana Biotechnology, Inc.
NASDAQ:SANA
Market cap
$605.26M
Shattuck Labs, Inc.
NASDAQ:STTK
Market cap
$473.57M
C4 Therapeutics, Inc.
NASDAQ:CCCC
Market cap
$362.43M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
Market cap
$351.57M
PepGen Inc.
NASDAQ:PEPG
Market cap
$301.98M
Quantum-Si incorporated
NASDAQ:QSI
Market cap
$229.78M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
Market cap
$172.64M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Market cap
$124.12M
Molecular Partners AG
NASDAQ:MOLN
Market cap
$112.71M
Nkarta, Inc.
NASDAQ:NKTX
Market cap
$85.23M
MediciNova, Inc.
NASDAQ:MNOV
Market cap
$68.66M
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 4, 2026 | |
| SC 13D | SC 13D filing | Nov 2, 2026 | |
| 8-K | Current report | Oct 29, 2026 |
How much cash does SEER have?
Seer, Inc. (SEER) reported $47.28M in cash and equivalents in fiscal 2025.
How much debt does SEER carry?
Seer, Inc. (SEER) reported $23.65M of total debt, with net debt of -$23.63M.
Continue the stock analysis
Jump to another research area for this company.